Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia

Cell Cycle

Volumn 10, Issue 11, 2011, Pages 1719-1725

  Watson, Alexander Scarth ^a   Mortensen, Monika ^b   Simon, Anna Katharina ^a,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acute myeloid leukemia; Atg7; Autophagy; Hematopoiesis; HSCs; Mitophagy; Myelodysplastic syndrome

Indexed keywords

ANGIOPOIETIN RECEPTOR; BECLIN 1; CD11B ANTIGEN; CD15 ANTIGEN; CRE RECOMBINASE; CYTOCHROME; CYTOCHROME C OXIDASE; DNA; IRON; LYSOSOME ENZYME; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOCHONDRIAL DNA; ONCOPROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE B; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TET ONCOGENE FAMILY MEMBER 2; UNCLASSIFIED DRUG; VAV PROTEIN;

5Q- SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ADAPTATION; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; BONE MARROW CELL; CARCINOGENESIS; CD34 SELECTION; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CELL TRANSFORMATION; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ABERRATION; COLONY FORMING UNIT; DEVELOPMENT; DISEASE COURSE; DNA DAMAGE; ERYTHROCYTE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNITY; KARYOTYPE; LETHALITY; LEUKEMOGENESIS; LEUKOCYTE; LYSOSOME; METHYLATION; MITOCHONDRION; MITOPHAGY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERINATAL DEATH; PERIPHERAL CIRCULATION; PHENOTYPE; POSITIVE FEEDBACK; PREVALENCE; PROGNOSIS; PROTEIN DEGRADATION; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; REFRACTORY CYTOPENIA WITH ULTILINEAGE DYSPLASIA; RETICULOCYTE; REVIEW; RISK; SIGNAL TRANSDUCTION; STARVATION; STEM CELL; T LYMPHOCYTE; THROMBOCYTE; TUMOR SUPPRESSOR GENE; UNIPARENTAL DISOMY;

MUS;

EID: 79957901938     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.11.15673     Document Type: Review

References (65)

1. Geng J, Klionsky DJ. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 2008; 9:859-64.
2. Levine B, Kroemer GCP. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42.
3. Rosenfeldt MT, Ryan KM. The multiple roles of autophagy in cancer. Carcinogenesis 2011; In Press
4. Rosenfeldt MT, Ryan KMC. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med 2009; 11:36.
5. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137:1062-75.
6. Mathew R, White ECP. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 2011; 21:113-9.
7. Farquhar MJ, Bowen DT. Oxidative stress and the myelodysplastic syndromes. Int J Hematol 2003; 77:342-50. (Pubitemid 37121829)
8. Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 2003; 27:95-120. (Pubitemid 36069077)
9. Cuijpers MLH, Raymakers RAP, MacKenzie MA, Witte TJM, Swinkels DW. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome. Br J Haematol 2010; 149:322-33.
10. Buckstein R, Jang K, Friedlich J, Zhang L, Reis M, Chesney A, et al. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows. Leuk Res 2009; 33:1313-8.
11. Estey E, Döhner H. Acute myeloid leukaemia. Lancet 2006; 368:1894-907. (Pubitemid 44794525)
12. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011; 12:9-14.
13. Mortensen M, Soilleux EJ, Djordjevic G, Tripp R, Lutteropp M, Sadighi-Akha E, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med 2011; 208:455-67.
14. Kundu M, Lindsten T, Yang CY, Wu JM, Zhao FP, Zhang J, et al. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood 2008; 112:1493-502.
15. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8:931-7. (Pubitemid 47622558)
16. Kent G, Minick OT, Volini FI, Orfei E. AUTOPHAGIC VACUOLES IN HUMAN RED CELLS. Am J Pathol 1966; 48:831-57.
17. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, Chen M, et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008; 454:232-5. (Pubitemid 351969889)
18. Zhang J, Randall MS, Loyd MR, Dorsey FC, Kundu M, Cleveland JL, et al. Mitochondrial clearance is regulated by Atg7-dependent and -independent mechanisms during reticulocyte maturation. Blood 2009; 114:157-64.
19. Mortensen M, Ferguson DJP, Simon AK. Mitochondrial clearance by autophagy in developing erythrocytes Clearly important, but just how much so? Cell Cycle 2010; 9:1901-6.
20. Koury MJ, Koury ST, Kopsombut P, Bondurant MC. In vitro maturation of nascent reticulocytes to erythrocytes. Blood 2005; 105:2168-74.
21. Pua HH, Guo J, Komatsu M, He YW. Autophagy Is Essential for Mitochondrial Clearance in Mature T Lymphocytes. J Immunol 2009; 182:4046-55.
22. Stephenson LM, Miller BC, Ng A, Eisenberg J, Zhao Z, Cadwell K, et al. Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes. Autophagy 2009; 5:625-35.
23. Mortensen M, Ferguson DJ, Edelmann M, Kessler B, Morten KJ, Komatsu M, et al. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci USA 2010; 107:832-7.
24. Liu F, Lee JY, Wei H, Tanabe O, Engel JD, Morrison SJ, et al. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 2010; 116:4806-14.
25. van de Loosdrecht AA, Brada SJL, Blom NR, Hendriks DW, Smit JW, et al. Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. Leuk Res 2001; 25:385-93. (Pubitemid 32294283)
26. Bader-Meunier B, Mielot F, Breton-Gorius J, Cramer E, Guichard J, Landrieu P, et al. Hematologic involvement in mitochondrial cytopathies in childhood: A retrospective study of bone marrow smears. Pediatr Res 1999; 46:158-62. (Pubitemid 29362727)
27. Lin CW, Manshouri T, Jilani I, Neuberg D, Patel K, Kantarjian H, et al. Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leuk Res 2002; 26:551-9. (Pubitemid 34462169)
28. Economopoulou C, Pappa V, Papageorgiou S, Kontsioti F, Economopoulou P, Charitidou E, et al. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS). Ann Hematol 2010; 89:349-58.
29. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants and aging. Cell 2005; 120:483-95.
30. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417:1-13.
31. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994; 54:1890-4.
32. Kirches E. Mitochondrial and nuclear genes of mitochondrial components in cancer. Curr Genomics 2009; 10:281-93.
33. Reddy PL, Shetty VT, Dutt D, York A, Dar S, Mundle SD, et al. Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes. Br J Haematol 2002; 116:564-75.
34. Linnartz B, Anglmayer R, Zanssen S. Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res 2004; 64:1966-71. (Pubitemid 38339441)
35. Shin MG, Kajigaya S, Levin BC, Young NS. Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 2003; 101:3118-25. (Pubitemid 36858005)
36. Wulfert M, Kupper AC, Tapprich C, Bottomley SS, Bowen D, Germing U, et al. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes. Exp Hematol 2008; 36:577-86. (Pubitemid 351551472)
37. Cohen AM, Alexandrova S, Bessler H, Mittelman M, Cycowitz Z, Djaldetti M. Ultrastructural observations on bone marrow cells of 26 patients with myelodysplastic syndromes. Leuk Lymphoma 1997; 27:165-72. (Pubitemid 27482933)
38. Szumiel I. Autophagy, reactive oxygen species and the fate of mammalian cells. Free Radic Res 2011; 45:253-65.
39. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 2003; 22:5501-10. (Pubitemid 37279959)
40. Downes CP, Walker S, McConnachie G, Lindsay Y, Batty IH, Leslie NR. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species. Biochem Soc Transact 2004; 32:338-42. (Pubitemid 38582123)
41. Lisanti MP, Martinez-Outschoorn UE, Chiavarina B, Pavlides S, Whitaker-Menezes D, Tsirigos A, et al. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor microenvironment. Cancer Biol Ther 2010; 10:537-42.
42. Houwerzijl EJ, Pol HW, Blom NR, van der Want JJ, de Wolf JT, Vellenga E. Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria. Leukemia 2009; 23:886-91.
43. Boultwood J, Fidler C, Mills KI, Frodsham PM, Kusec R, Gaiger A, et al. Amplification of mitochondrial DNA in acute myeloid leukaemia. Br J Haematol 1996; 95:426-31. (Pubitemid 26360237)
44. Essick EE, Sam FCP. Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid Med Cell Longev 2010; 3:168-77.
45. Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Manzoli L, McCubrey JA. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia. Expert Opin Investig Drugs 2009; 18:1333-49.
46. Horn S, Bergholz U, Jucker M, McCubrey JA, Trumper L, Stocking C, et al. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells. Oncogene 2008; 27:4096-106. (Pubitemid 351931986)
47. Recher C, Beyne-Rauzy O, Demur C, Chicanne G, Dos Santos C, Mas VM, et al. Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 2005; 105:2527-34. (Pubitemid 40387055)
48. Isakson P, Bjoras M, Boe SO, Simonsen A. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood 2010; 116:2324-31.
49. Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP. Characterization of gene expression of CD34(+) cells from normal and myelodysplastic bone marrow. Blood 2002; 100:3553-60. (Pubitemid 35303923)
50. Lee S, Chen JJ, Zhou GL, Shi RZ, Bouffard GG, Kocherginsky M, et al. Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. Proc Natl Acad Sci USA 2006; 103:1030-5.
51. Mills KI, Kohlmann A, Williams PM, Wieczorek L, Liu WM, Li R, et al. Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome. Blood 2009; 114:1063-72.
52. Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia 2010; 24:756-64.
53. Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 2009; 460:904-8.
54. Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009; 113:1315-25.
55. Bacher U, Haferlach C, Schnittger S, Kohlmann A, Kern W, Haferlach T. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies. Ann Hematol 2010; 89:643-52.
56. Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466:68-76.
57. Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci USA 2009; 106:12950-5.
58. Akagi T, Ogawa S, Dugas M, Kawamata N, Yamamoto G, Nannya Y, et al. Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype. Haematologica 2009; 94:213-23.
59. Rucker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Frohling S, et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006; 24:3887-94. (Pubitemid 46630736)
60. Dunwell T, Hesson L, Rauch TA, Wang LH, Clark RE, Dallol A, et al. A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer 2010; 9:44.
61. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 2009; 217:702-6.
62. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6. (Pubitemid 129516338)
63. Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH, et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006; 8:688-98.
64. White E, Karp C, Strohecker AM, Guo Y, Mathew RC. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 2010; 22:212-7.
65. Altman BJ, Jacobs SR, Mason EF, Michalek RD, MacIntyre AN, Coloff JL, et al. Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 2011; 30:1855-67.